Dr. Gregory is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9040 Jackson Ave
Tacoma, WA 98433
Summary
- Dr. Timothy Gregory is a Neurologist based in Houston, TX, with a subspecialty in Neurooncology. He earned his MD from the UniforMed Services University of the Health Sciences F. Edward Hebert School of Medicine in 2017 and completed his residency in Neurology at the Madigan Army Medical Center from 2017 to 2021, where he continued to work as a neurologist. Prior to his MD, he completed a BS in Natural Sciences at the University of Pittsburgh. Dr. Gregory has several prominent publications in journals such as the Journal of Neuro-Oncology, Journal of Immunotherapy and Precision Oncology, and Neuro-Oncology Advances. His research has been cited multiple times.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2021 - 2023
Madigan Army Medical CenterResidency, Neurology, 2017 - 2021
Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2017, MD
University of PittsburghBS, Natural Sciences, 2010 - 2013
Certifications & Licensure
WA State Medical License 2023 - 2026- American Board of Psychiatry and Neurology Neurology
- UCNSNeuro-Oncology
Publications & Presentations
PubMed
- Differential diagnosis in immune checkpoint inhibitors neurotoxicity.Catherine R Garcia, Ian J Robertson, Timothy A Gregory, Anza Zahid, Behrang Amini
Journal of Neurology. 2025-01-15 - 2 citationsAccelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study.Timothy A Gregory, Stephanie R Knight, Ashley E Aaroe, Kaitlin N Highsmith, Zachary C Janatpour
Neuro-Oncology Practice. 2024-08-01 - The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.Pushan Dasgupta, Alexander Ou, Heather Lin, Timothy Gregory, Kristin D Alfaro-Munoz
Journal of Neuro-Oncology. 2024-03-01
Journal Articles
- Cortical T2-hyperintense lesions as the initial MRI finding in glioblastomaGregory TA, Henson JW, Interdisciplinary Neurosurgery, 10/25/2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
